News / Business
Speak with other shareholders about: (OTC BB: FGOC), (OTCBB: SWRI), (Nasdaq: ATRC), and (OTCBB: CRDM) .
----------------------------------------------------------
Chat real-time with other investors about this FGOC news release, by clicking this link: http://www.stockwire.com/FGOC
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=FGOC
Firstgold Corp. (OTCBB: FGOC) Current Price (0.68)
CAMERON PARK, CA----May 31, 2007 -- Firstgold Corp. (OTCBB: FGOC) announced today that it has completed its current round of drilling at the Relief Canyon Mine. Consisting of over 58 drill holes, and using sonic drilling, Firstgold Corp. has sought to improve its understanding of the gold content in the existing heap leach pads. Firstgold Corp. engages in the acquisition, development, exploration, and production of gold-bearing properties in North America. The company?s principal property includes the Relief Canyon mine project in Nevada, which consists of 78 claims, including 57 mill site claims and 21 unpatented mining claims. It also has a joint venture to explore additional mining properties known as the Red Caps Project and Crescent Valley Project comprising approximately 135 unpatented mining claims located in Lander County, Nevada. The company was founded in 1993 as Newgold, Inc. and changed its name to Firstgold Corp. in 2006. Firstgold Corp. is headquartered in Cameron Park, California.
----------------------------------------------------------
Chat real-time with other investors about this SWRI news release, by clicking this link: http://www.stockwire.com/SWRI
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=SWRI
Seawright Holdings, Inc. (OTCBB: SWRI) Current Price (0.98)
EL DORADO HILLS, Calif.--July 9--Dutton Associates updates its coverage of Seawright Holdings Inc. (OTCBB: SWRI), revising its rating from Speculative Buy to Neutral. We would note that although the stock has more than doubled since our Initial Report was published on December 13, 2006 the shares remain attractively priced relative to our assessment of asset value. The 8-page report by Dutton Associates senior analyst Jonathan H. Ziegler, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, and Knobias and other leading financial portals. Seawright Holdings owns Seawright Springs, located in Augusta County, Virginia, which produces in excess of 1 million gallons of water a day and is one of the largest sources of fresh natural spring water on the Eastern Seaboard. Seawright is seeking approval to ship into 50 states; however, its immediate strategy is to focus on the large population base that lives within a day's drive of its natural spring in Virginia. Seawright Holdings, Inc. (OTC BB:SWRI - News) owns Seawright Springs, the producer of one of America's purest, freshest and high-mineral content drinking waters. Seawright Springs is located in beautiful Augusta County, Virginia on 145 acres of protected woodlands. The spring produces in excess of 1 million gallons of water a day and is one of the largest sources of fresh natural spring water on the Eastern Seaboard. In 2003, Joel Sens formed Seawright Holdings, Inc. and purchased Seawright Springs to begin producing high quality bottled water under the Seawright Springs brand.
----------------------------------------------------------
Chat real-time with other investors about this ATRC news release, by clicking this link: http://www.stockwire.com/ATRC
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=ATRC
AtriCure Inc. (Nasdaq: ATRC) Current Price (9.34)
WEST CHESTER, Ohio - July 9 -- Medical device maker AtriCure Inc. said Monday the Food and Drug Administration approved its clamp system for heart surgery. AtriCure, Inc. engages in the development, manufacture, and sale of surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues. It offers the AtriCure Isolator bipolar ablation system, which consists of an ablation sensing unit, a compact power generator that uses its proprietary software and delivers bipolar radio-frequency energy; multiple configurations of its Isolator bipolar ablation clamps; and its multifunctional bipolar Pen. The company also provides Isolator bipolar ablation clamps designed for ablation during open procedures; Isolator Synergy ablation clamps, which are designed to provide full thickness lesions in thicker and more diseased tissues; and endoscopic Isolator bipolar ablation clamps designed for use in minimally invasive procedures. In addition, it offers multifunctional bipolar Pen for the surgical ablation of cardiac tissue; and for temporary pacing, sensing, stimulating, and recording during the evaluation of cardiac arrhythmias. Further, the company sells Lumitip dissector for the dissection of soft tissues during general, thoracic, and certain other surgical procedures; and distributes cryoablation devices that use extreme cold to ablate tissue. AtriCure sells its medical devices through its direct sales force to hospitals and medical clinics primarily in the United States, as well as through distributors in Asia, Europe, Canada, the Middle East, Central America, and South America. The company was founded in 2000 and is headquartered in West Chester, Ohio.
----------------------------------------------------------
Chat real-time with other investors about this CRDM news release, by clicking this link: http://www.stockwire.com/CRDM
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=CRDM
Cardima, Inc. (OTCBB: CRDM) Current Price (0.05)
FREMONT, CA----Jul 9, 2007 -- Cardima, Inc. (OTCBB: CRDM), developer of the REVELATION Tx, REVELATION T-Flex and REVELATION Helix ablation microcatheters and INTELLITEMP Energy Management Device, hosted a satellite symposium on July 7th, 2007 at the China Atrial Fibrillation Symposium held in Beijing. Cardima, Inc. has developed the REVELATION Tx, REVELATION T-Flex and REVELATION Helix linear ablation microcatheters, the NAVIPORT deflectable guiding catheters, and the INTELLITEMP energy management system for the minimally invasive treatment of atrial fibrillation. The REVELATION Tx, REVELATION T-Flex and REVELATION Helix systems and the INTELLITEMP have received CE Mark approval in Europe. The Company has also developed and obtained marketing clearance in the USA for a Surgical Ablation System, which is used by cardiac surgeons to ablate cardiac tissue during heart surgery using radio frequency (RF) energy.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire: Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
